A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment of Cancer Associated Thrombosis (ALICAT): study protocol for a mixed-methods study

BACKGROUND: Venous thromboembolism is common in patients with cancer and requires anticoagulation with low molecular weight heparin. Current data informs anticoagulation as far as six months, yet guidelines recommend anticoagulation beyond six months in patients who have locally advanced or metastat...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Joanna D, Baillie, Jessica, Baglin, Trevor, Griffiths, Gareth O, Casbard, Angela, Cohen, David, Fitzmaurice, David A, Hood, Kerenza, Rose, Peter, Cohen, Alexander T, Johnson, Miriam, Maraveyas, Anthony, Bell, John, Toone, Harold, Nelson, Annmarie, Noble, Simon I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003288/
https://www.ncbi.nlm.nih.gov/pubmed/24726032
http://dx.doi.org/10.1186/1745-6215-15-122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003288/
https://www.ncbi.nlm.nih.gov/pubmed/24726032
http://dx.doi.org/10.1186/1745-6215-15-122

Ejemplares similares